Entera Bio Competitors and Similar CompaniesClear all
Entera Bio's competitors and similar companies include Aerie Pharmaceuticals.
 Entera Bio Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 2010 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Wellesley, US HQ Jerusalem, IL | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 1616% decrease | Employees 3808% increase |
Valuation ($) | Valuation ($) 68.7 m | Valuation ($) 722.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $42k (FY, 2025) | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods $42k (FY, 2025) | Cost of goods $26.8m (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company